ImmunityBio, Inc. IBRX Short-term debt and current portion of long-term debt
Short-term debt and current portion of long-term debt at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DebtCurrent.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s short-term debt and current portion of long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s short-term debt and current portion of long-term debt?
- ImmunityBio, Inc. (IBRX) reported short-term debt and current portion of long-term debt of $884K in Q1 2026.